Skin lesions on the patient’s forearms were counted before the immunotherapy started, and then again at three, six and 12-month...

In a new study, researchers have identified benefits of SARS-COV-2 mRNA vaccines for cancer patients undergoing immunotherapy. The...

Phase III studies of a personalized vaccine plus immunotherapy for melanoma have been launched at cancer centres around the world,...

A new finding suggests that a combination of immunotherapies will help patients with aggressive melanoma resistant to PD-1 inhibitors....

A study from the University of Alberta has identified genetic mutations in scleroderma patients, a finding that may lead to new...

Data collected from 21 melanoma referral centres in the U.S., Europe, and Australia reveals that, over the last five years, the use of...

A new study suggests that with current immunosuppressive therapies, 20% of people with early or at-risk dcSSc experienced worsening of skin.

An analysis of real-world data has evaluated the incidence, type and severity of skin-related side effects of immune checkpoint inhibitors.